Faculty Opinions recommendation of Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: a double-blind, randomised controlled trial.

Author(s):  
Bradley Quon
The Lancet ◽  
2020 ◽  
Vol 395 (10227) ◽  
pp. 878-887 ◽  
Author(s):  
Michael D Hill ◽  
Mayank Goyal ◽  
Bijoy K Menon ◽  
Raul G Nogueira ◽  
Ryan A McTaggart ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document